IL17A and COVID-19: In addition, the ACLF+COVID-19 group had higher IL-6 levels (161.43 [82.75 - 479.9)] vs 7.96 [29.3-18.54]; p=0.004), IL-8 levels (302.77 ± 264.24 vs 7.53 ± 9.24; p=0.041), and IL-17 levels (28.89 ± 24.43 vs 0 [0-2.76]; p=0.022) than the COVID-19 group (Table 3).